{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T02:21:19Z","timestamp":1787192479245,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011680","name":"King Fahad Medical City","doi-asserted-by":"publisher","award":["IRF# 018-001"],"award-info":[{"award-number":["IRF# 018-001"]}],"id":[{"id":"10.13039\/501100011680","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005725","name":"National Plan for Science, Technology and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004919","name":"King Abdulaziz City for Science and Technology","doi-asserted-by":"publisher","award":["08-MED513-02"],"award-info":[{"award-number":["08-MED513-02"]}],"id":[{"id":"10.13039\/501100004919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jdiacomp.2024.108910","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T08:13:11Z","timestamp":1732090391000},"page":"108910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Predictors of liver fibrosis progression in cohort of type 2 diabetes mellitus patients with MASLD"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4792-5188","authenticated-orcid":false,"given":"Assim A.","family":"Alfadda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel N.","family":"Alqutub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suphia M.","family":"Sherbeeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah S.","family":"Aldosary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh A.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Isnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukhsana","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad S.","family":"Khaleel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Alqasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman M.","family":"Almaghamsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2024.108910_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101133","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2024","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.21037\/tgh.2019.10.02","article-title":"Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis","volume":"5","author":"Sharma","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0015","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2147\/CLEP.S144368","article-title":"Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes","volume":"9","author":"Simeone","year":"2017","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0020","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43856-022-00228-y","article-title":"A multistakeholder approach to innovations in NAFLD care","volume":"3","author":"Schattenberg","year":"2023","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0030","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0035","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","article-title":"Clinical epidemiology and disease burden of nonalcoholic fatty liver disease","volume":"23","author":"Perumpail","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1030661","article-title":"Alterations in circulating lipidomic profile in patients with type 2 diabetes with or without non-alcoholic fatty liver disease","volume":"10","author":"Alfadda","year":"2023","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0050","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4103\/sjg.sjg_73_22","article-title":"Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: evidence from the CORDIAL cohort study","volume":"28","author":"Alfadda","year":"2022","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0055","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1542-3565(04)00014-X","article-title":"Nonalcoholic fatty liver disease in patients with type 2 diabetes","volume":"2","author":"Younossi","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0060","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/sjg.SJG_122_18","article-title":"Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030","volume":"24","author":"Alswat","year":"2018","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0070","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1016\/j.sjbs.2021.05.063","article-title":"Prevalence and predictors of non-alcoholic fatty liver disease in tertiary care hospital of Taif, Saudi Arabia: a retrospective study","volume":"28","author":"Alamri","year":"2021","journal-title":"Saudi J Biol Sci"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0075","article-title":"Diagnostic accuracy of FibroScan and factors affecting measurements","volume":"10","author":"Oeda","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/liv.14274","article-title":"Liver fibrosis by FibroScan(\u00ae) independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes","volume":"40","author":"Lombardi","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.gtc.2019.02.002","article-title":"Liver fibrosis determination","volume":"48","author":"Lai","year":"2019","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fphar.2016.00159","article-title":"Non-invasive markers of liver fibrosis: adjuncts or alternatives to liver biopsy?","volume":"7","author":"Chin","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155642","article-title":"Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States","volume":"146","author":"Golabi","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0100","first-page":"295","article-title":"Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study","volume":"5","author":"Abeysekera","year":"2020","journal-title":"Lancet Gastroenterol"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.917304","article-title":"Nomogram for quantitatively estimating the risk of fibrosis progression in type 2 diabetic patients with nonalcoholic fatty liver disease: a pilot study","volume":"13","author":"Xia","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0110","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0115","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/hep.31142","article-title":"Serial transient elastography examinations to monitor patients with type 2 diabetes: a prospective cohort study","volume":"72","author":"Lee","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0120","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/liv.15255","article-title":"Repeated measurements of non-invasive fibrosis tests to monitor the progression of non-alcoholic fatty liver disease: a long-term follow-up study","volume":"42","author":"Balkhed","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0125","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0041-1730927","article-title":"Insights into nonalcoholic fatty-liver disease heterogeneity","volume":"41","author":"Arrese","year":"2021","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.15605\/jafes.038.01.08","article-title":"The prevalence of advanced liver fibrosis among patients with type 2 diabetes mellitus: a single-centre experience in Penang, Malaysia","volume":"38","author":"Lee","year":"2023","journal-title":"J ASEAN Fed Endocr Soc"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0135","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s10620-021-06955-x","article-title":"Progression of nonalcoholic fatty liver disease-associated fibrosis in a large cohort of patients with type 2 diabetes","volume":"67","author":"Noureddin","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0140","first-page":"721","article-title":"High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients","volume":"15","author":"Arab","year":"2016","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2023.01.083","article-title":"Evolution of liver fibrosis in diabetic patients with NAFLD in a follow-up study: hepatoprotective effects of sodium-glucose co-transporter-2 inhibitors","author":"Lombardi","year":"2023","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0150","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/gutjnl-2015-309265","article-title":"Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study","volume":"65","author":"Kwok","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0155","doi-asserted-by":"crossref","first-page":"661","DOI":"10.5152\/tjg.2021.20512","article-title":"Evaluation of the impact of metabolic syndrome on fibrosis in metabolic dysfunction-associated fatty liver disease","volume":"32","author":"Kani","year":"2021","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.21037\/tgh-22-1","article-title":"Association between body mass index and liver stiffness measurement using transient elastography in patients with non-alcoholic fatty liver disease in a hepatology clinic: a cross sectional study","volume":"8","author":"Gopalakrishna","year":"2023","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0165","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.3748\/wjg.v26.i38.5849","article-title":"Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis","volume":"26","author":"Gotlieb","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23270","article-title":"The value of platelet count in evaluating the degree of liver fibrosis in patients with chronic hepatitis B","volume":"34","author":"Zhong","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0175","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/curroncol29030124","article-title":"Low platelet count predicts reduced survival in potentially resectable hepatocellular carcinoma","volume":"29","author":"Schrecker","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0180","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/1479164110383994","article-title":"Platelet abnormalities in diabetes mellitus","volume":"7","author":"Ferreiro","year":"2010","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0185","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12944-018-0865-7","article-title":"Risk of reduced platelet counts in patients with nonalcoholic fatty liver disease (NAFLD): a prospective cohort study","volume":"17","author":"Liu","year":"2018","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021703","article-title":"GLP-1 receptor agonists in non-alcoholic fatty liver disease: current evidence and future perspectives","volume":"24","author":"Nevola","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.769069","article-title":"Efficacy and safety of GLP-1 receptor agonists in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0200","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0205","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/496453","article-title":"The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone","volume":"2012","author":"Ohki","year":"2012","journal-title":"Scientific World Journal"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.935180","article-title":"Association between use of liraglutide and liver fibrosis in patients with type 2 diabetes","volume":"13","author":"Tan","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/apt.15316","article-title":"Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and\/or obesity","volume":"50","author":"Newsome","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0220","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/hep.23569","article-title":"Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway","volume":"51","author":"Gupta","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0225","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jdi.12065","article-title":"Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: incretin actions beyond the pancreas","volume":"4","author":"Seino","year":"2013","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.jdiacomp.2024.108910_bb0230","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/liv.12120","article-title":"GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK","volume":"33","author":"Zhang","year":"2013","journal-title":"Liver Int"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724002368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724002368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T11:53:19Z","timestamp":1739015599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872724002368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1056872724002368"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108910","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of liver fibrosis progression in cohort of type 2 diabetes mellitus patients with MASLD","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024","name":"copyright","label":"Copyright"}],"article-number":"108910"}}